3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Neoplasms
2
Skin Carcinoma
1
Patient Satisfaction
1
Hematologic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Interventions
HhAntag691
14
Biopsy
8
Imiquimod
7
Aminolevulinic Acid
7
sonidegib
6
Tomography, Optical Coherence
6
Surgical Procedures, Operative
6
Photochemotherapy
6
Mohs Surgery
6
1-phenyl-3,3-dimethyltriazene
6
Radiotherapy
5
Itraconazole
5
Nivolumab
4
Microscopy, Confocal
4
Curettage
4
pembrolizumab
3
methyl 5-aminolevulinate
3
cemiplimab
3
Standard of Care
3
Niacinamide
3
tazarotene
2
relatlimab
2
X-Rays
2
Watchful Waiting
2
Specimen Handling
2
Observation
2
Magnetic Resonance Spectroscopy
2
Laser Therapy
2
Gene Expression Profiling
2
Eflornithine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Basal Cell
×
Aftercare
×
Clear all
NCT07347392
2026-01-16
DOSCA-2
University of Aarhus
Enrolling by invitation
2,900 enrolled